Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction

NANot yet recruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

April 30, 2025

Study Completion Date

July 31, 2025

Conditions

Small Bowel AdhesionSmall Bowel Obstruction

Interventions

PROCEDURE

Low osmolar contrast

100 mL of 350 mg omnipaque will be administered via nasogastric tube

PROCEDURE

Sterile water

100 mL of sterile water will be administered via nasogastric tube

All Listed Sponsors

lead

Queen Savang Vadhana Memorial Hospital, Thailand

OTHER

NCT06140173 - Low-osmolar Water Soluble Contrast Agent in Management of Adhesive Small Bowel Obstruction | Biotech Hunter | Biotech Hunter